A U.S. appeals court struck down key parts of an Oklahoma law designed to regula...
A combination of strict eligibility criteria and special requirements for insura...
With its future in doubt, ProMED, the financially strapped infectious diseases s...
“We like being included. One of my love languages or manifestations of my love l...
The often-irreversible damage experienced by physicians and medical students who...
Astellas Pharma has announced that EMA has accepted the MAA from its subsidiary ...
Nuvectis Pharma has received US Food and Drug Administration (FDA) orphan drug d...
The US Circuit Court of Appeals restricted the prescription of abortion pills, f...
The decision brings the first daily oral migraine prophylactic to Europe, with p...
Depending on Phase III results, survodutide could soon enter the weight loss mar...
Imugene's azercabtagene zarpreleucel (azer-cel) allo-CAR T cell therapy has show...
As restrictions on abortion drug mifepristone loom, doctors and patients are loo...
Coeptis Therapeutics has exclusively licensed allogeneic immuno-oncology platfor...
Bruker has entered into a definitive agreement to acquire functional cell biolog...
Competitive intelligence is a vital tool of the research and analysis toolbox fo...
What difference does a day make? How do you mail a gene therapy? And are biotech...
